Evidence map›Paper›PMID 31581382›Full record

ArticleJournal of microbiology and biotechnology2020

Purification and Characterization of

Asmaa M Arafa, Afaf E Abdel-Ghany, Samih I El-Dahmy, Sahar Abdelaziz, Yassin El-Ayouty, Ashraf S A El-Sayed

Open access · hybridAbstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Metallic nanoparticles: a promising novel therapeutic tool against antimicrobial resistance and spread of superbugs.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Biochemical Properties of Tyrosinase fromMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Asmaa M ArafaDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Afaf E Abdel-GhanyDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Samih I El-DahmyDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Sahar AbdelazizDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Yassin El-AyoutyEnzymology and Fungal Biotechnology Lab (EFBL), Botany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Ashraf S A El-SayedEnzymology and Fungal Biotechnology Lab (EFBL), Botany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Zagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenylalanine ammonia-lyase (PAL) catalyzes the reversible deamination of phenylalanine to cinnamic acid and ammonia. Algae have been considered as biofactories for PAL production, however, biochemical characterization of PAL and its potency for myristicin biotransformation into MMDA (3-methoxy-4, 5-methylenedioxyamphetamine) has not been studied yet. Thus, PAL from

Indexed as

3,4-MethylenedioxyamphetamineAllylbenzene DerivativesBacterial ProteinsBenzyl CompoundsBiotransformationDioxolanesDolichospermum flos-aquaeHydrogen-Ion ConcentrationMolecular StructureMolecular WeightPhenylalanine Ammonia-LyasePyrogallolSpirulinaSubstrate SpecificityTemperature3,4-MethylenedioxyamphetamineAllylbenzene DerivativesBacterial ProteinsBenzyl CompoundsDioxolanesMMDAmyristicinPhenylalanine Ammonia-LyasePyrogallolMMDAmyristicinPhenylalanine ammonia-Lyasepropertiespurification

Identifiers

PMID31581382
PMCPMC9728195
OpenAlexW2996614535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.